Inkef Capital

Firm Name: INKEF Capital Investment Thesis: Patient, long-term capital backing transformative healthcare and technology companies across Europe. Focus: HealthTech, BioTech, Therapeutics, Medical Devices, Enterprise & FinTech Software Stage: Seed to Series A (occasionally growth rounds) Geography: Amsterdam-based, investing broadly across Netherlands and Europe (also U.S. on select deals) Notable Portfolio Companies: GitLab, Remote, Urban Sports Club, QurAlis, Precirix Description: INKEF Capital, founded in 2010 in Amsterdam by Dutch pension fund ABP and Canada’s OMERS, is a long-term, patient VC partner backing early-stage ventures at the intersection of health and technology. With investment tickets typically ranging from €0.5–15 million, the firm supports founders from seed through Series A—and sometimes beyond—focused on lasting, impactful company-building. INKEF’s portfolio spans deep health-tech (e.g., QurAlis, Precirix) and software/enterprise (e.g., GitLab, Remote, Urban Sports Club) across Europe and occasionally the U.S. The team of ~20 professionals emphasizes active mentorship, sector expertise in life sciences and software, and multi‑round support through IPOs or exits. Even after LP ABP shifted its focus in 2023, INKEF maintains capital reserves to back its existing portfolio for years and continues investing in breakthrough innovation across its core domains.